Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 18, 1996

Conditions
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
Interventions
DRUG

G-CSF

After medical clearance, volunteers will undergo outpatient mobilization with daily subcutaneous injections of filgrastim (G-CSF). The first dose will be administered at the NIH Clinical Center, with one-hour monitoring for immediate reactions. Volunteers may either return to NIH for daily injections or self-administer at home after training.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
collaborator

New York University and New York Genome Center

UNKNOWN

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH